NCM · Biotechnology

ICU (ICU) Stock

$3.47 -2.80% NCM: ICU Healthcare

Valuation

MetricValue
Price$3.47
Market Cap$9.85M
P/E Ratio-0.68
P/B Ratio1.13
P/S Ratio7.73
EPS (TTM)$-5.86
52-Week High$12.50
52-Week Low$2.07
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-120.00%
ROA-85.71%
ROCE-120.00%
Gross Margin-1200.00%
Operating Margin-1200.00%
Net Margin-8.29%
Debt/Equity0.05
Current Ratio3.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-4.0M$-12.0M$-14.0M$-18.0M$-12.0M
Net Profit$-5.0M$-12.0M$-26.0M$-25.0M$-12.0M
EPS$-88.10$-233.80$-302.62$-66.30$-5.86
Op Margin———-13216.3%-986.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$3.0M$4.0M$5.0M$14.0M
Total Liabilities$3.0M$24.0M$17.0M$7.0M$4.0M
Cash$1.0M$0$0$2.0M$12.0M
Borrowings$3.0M$9.0M$9.0M$1.0M$1.0M

Latest News

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI) GlobeNewswire · Jul 14, 2026 Q2 Virtual Investor Summit Presentations Now Available On Demand ACCESS Newswire · Jun 30, 2026 Q2 Investor Summit Virtual Live Wednesday June 24 ACCESS Newswire · Jun 23, 2026 SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury GlobeNewswire · Jun 23, 2026 SeaStar Medical to Present at Upcoming Investor Summit Conference GlobeNewswire · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-8.0M$-10.0M$-16.0M$-14.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$-6.0M$0$5.0M$0
Net Cash Flow$0$0$0$2.0M$10.0M
Free Cash Flow$-5.0M$-8.0M$-10.0M$-16.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-123.52%
Quick Ratio2.71
Interest Coverage—
Return 1Y-17.20%
Return 3Y-96.60%
Return 5Y-99.81%

Ownership

Insiders Held12.80%
Institutions Held7.66%
Institutions Float Held8.78%
Institutional HolderSharesReport Date
Geode Capital Management, LLC55,6422026-03-31
Vanguard Capital Management LLC28,7912026-03-31
Jane Street Group, LLC27,9602026-03-31
Vanguard Fiduciary Trust Co13,6922026-03-31
PNC Financial Services Group, Inc.1,7482026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADTX $0.01 -77.22% -0.01 $318 0.00%
AIMD $1.49 -3.87% -0.43 $10.97M 0.00%
APLMApollomics, Inc. $18.76 +2.99% -2.41 $20.69M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
BLRXBioLineRx Ltd. $2.85 -2.45% -1.36 $12.39M 0.00%

About ICU

ICU is led by CEO Eric Schlorff, employs 19 people, headquartered in US, publicly traded since 2021.

ICU stock trades at $3.47 with a market capitalization of $9.85M. The stock is valued at a price-to-earnings (P/E) ratio of -0.68, price-to-book of 1.13, price-to-sales of 7.73. Over the past 52 weeks the stock has ranged between $2.07 and $12.50, and currently trades 72.2% below its 52-week high.

On profitability, ICU generates a return on equity (ROE) of -120.00%, return on capital employed of -120.00%, an operating margin of -1200.00%, a net profit margin of -8.29%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides